Kexin Huang is a fourth-year PhD student in Computer Science at Stanford University, advised by Prof. Jure Leskovec. His research focuses on leveraging AI to drive novel, deployable, and interpretable biomedical discoveries, while also tackling fundamental AI challenges such as multi-modal modeling, uncertainty quantification, and agentic reasoning. His work has been published in Nature Medicine, Nature Biotechnology, Nature Chemical Biology, Nature Biomedical Engineering, and machine learning conferences including NeurIPS, ICML, ICLR, and UAI. His research has been featured in major media outlets such as Forbes, WIRED, and MIT Technology Review. He has also contributed to machine learning research at leading companies and institutions, including Genentech, GSK, Pfizer, IQVIA, Flatiron Health, Dana-Farber Cancer Institute, and Rockefeller University.